-+ 0.00%
-+ 0.00%
-+ 0.00%

Whitehawk Therapeutics Q4 EPS $(0.34) Misses $(0.13) Estimate

Benzinga·03/12/2026 12:15:11
Listen to the news
Whitehawk Therapeutics (NASDAQ:WHWK) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.13) by 172 percent. This is a 49.25 percent increase over losses of $(0.67) per share from the same period last year.